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ABSTRACT
The Wnt signaling pathway plays crucial roles during
embryonic development, whose aberration is implicated
in a variety of human cancers. Axin, a key component
of canonical Wnt pathway, plays dual roles in modulat-
ing Wnt signaling: on one hand, Axin scaffolds the
“β-catenin destruction complex” to promote β-catenin
degradation and therefore inhibits the Wnt signal
transduction; on the other hand, Axin interacts with
LRP5/6 and facilitates the recruitment of GSK3 to the
plasma membrane to promote LRP5/6 phosphorylation
and Wnt signaling. The differential assemblies of Axin
with these two distinct complexes have to be tightly
controlled for appropriate transduction of the “on” or
“off” Wnt signal. So far, there are multiple mechanisms
revealed in the regulation of Axin activity, such as post-
transcriptional modulation, homo/hetero-polymerization
and auto-inhibition. These mechanisms may work
cooperatively to modulate the function of Axin, thereby
playing an important role in controlling the canonical
Wnt signaling. In this review, we will focus on the recent
progresses regarding the regulation of Axin function in
canonical Wnt signaling.
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INTRODUCTION
Wnt signaling is one of the most conserved pathways during
evolution, playing essential roles in multiple biological pro-
cesses like embryonic development and adult tissue
homeostasis. Dysregulation of theWnt pathway underlies the
pathogenesis of a variety of human cancers. So far, two types
of Wnt signaling pathways have been characterized: canon-
ical Wnt pathway (also known asWnt/β-catenin pathway) and
noncanonical Wnt pathway (including planar cell polarity
pathway and Wnt/calcium pathway). The Wnt/β-catenin
pathway is distinguished from the others in the way of its
dependency on β-catenin, which is nevertheless not required
for the two noncanonical Wnt pathways. As a central player in
canonical Wnt signaling, β-catenin dictates the signaling
intensity through its cellular levels and subcellular localiza-
tion. In the absence ofWnt signaling, β-catenin is sequestered
in the cytoplasm by the “destruction complex” composed of
Axin, glycogen synthase kinase 3 (GSK3) and adenomatous
polyposis coli (APC), etc. β-catenin is phosphorylated by
GSK3and subsequently subjected to degradation through the
ubiquitin-proteasome pathway. Upon Wnt stimulation, low-
density lipoprotein receptor-related proteins 5/6 (LRP5/6) is
co-clustered with Frizzled (Fz) and Dishevelled (Dvl) and
recruits the active Axin and GSK3 complex; these proteins
thus form a high-molecular-weight assemblage close to the
plasma membrane that is referred to as “LRP signalosome”
(Bilic et al., 2007). Following the recruitment of Axin to LRP5/
6, the “destruction complex” is disassembled; and β-catenin is
released and translocates into the nucleus, where it forms a
transcriptional complex with LEF-1/TCF and activates the
transcription of Wnt-responsive genes. Recently, Li et al.,
based on their ﬁndings, proposed an alternative model that
Wnt stimulation, rather than cause the disassembly of
“destruction complex”, suppresses β-catenin degradation and
leads to saturation of the complex by the accumulated
β-catenin, thus sparing the newly synthesized β-catenin,
which accumulates in a free cytosolic form and consequently
enters the nucleus to bind LEF-1/TCF (Li et al., 2012).
Vertebrates have two Axin isoforms: Axin1 (also referred
to as Axin) is constitutively expressed, while Axin2 (also
called Conductin) is subjected to the regulation of Wnt
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signaling (Jho et al., 2002; Leung et al., 2002; Yan et al.,
2001). Albeit different in their expression patterns, Axin and
Axin2 appear to be functionally, at least partly, interchange-
able in canonical Wnt pathway (Chia and Costantini, 2005).
Considering its essential role in both “destruction complex”
and “LRP signalosome”, the activity of Axin has to be tightly
controlled. Post-translational modiﬁcation is the most com-
mon mechanism for regulating protein activity. Several ways
of modiﬁcations, such as phosphorylation, SUMOylation and
ubiquitination, have been reported to play a role in regulating
Axin stability, sub-cellular localization or association with
other proteins (Callow et al., 2011; Fei et al., 2013; Kim et al.,
2008; Kim and Jho, 2010; Zhang et al., 2011). Polymeriza-
tion of Axin also regulates its activity in a way that currently
isn’t clearly deﬁned. Axin is considered as a protein that is
largely unstructured except the N-terminal RGS domain
responsible for binding APC and the C-terminal DIX domain
for mediating oligomerization. Besides Axin, Dvl and Ccd1
also contain a DIX domain, which is responsible for their
homo- and hetero- polymerization (Liu et al., 2011; Schwarz-
Romond et al., 2007a; Shiomi et al., 2003). It is reported that
DIX-mediated heterotypic interaction between Axin and Dvl
may disrupt Axin’s association with the “destruction com-
plex” and facilitate its recruitment to the “LRP signalosome”
(Mendoza-Topaz et al., 2011; Schwarz-Romond et al.,
2007b). Recently, two independent researches carried out
by Sung-Eun Kim et al. and our group revealed a new
mechanism of “auto-inhibition” behind Axin function, pointing
out that conformational changes of Axin may play an
important role in regulating its activity (Kim et al., 2013b;
Wang et al., 2013). Notably, these mechanisms may be
relevant and work cooperatively to ﬁne-tune and regulate the
function of Axin.
UBIQUITINATION/SUMOYLATION OF AXIN
Ubiquitination is an important regulatory process for protein,
playing diverse roles in modulating protein function. Ubiquitin
is covalently attached to the targeted molecules through the
sequential activities of three enzymes: ubiquitin-activating
enzyme (E1) for ATP-dependent activation of ubiquitin (Ub),
ubiquitin-conjugating enzyme (E2) for delivery of Ub, and
ubiquitin ligase (E3) for ligation of Ub to the substrates. In
this process, the E3 ligases are responsible for substrate
selection and the speciﬁcity of Ub-linkage. There are seven
lysines (K6, K11, K27, K29, K33, K48 and K63) in Ub mol-
ecule. Generally, proteins marked by K48-linked poly-Ub
chains are destined to proteasome-dependent degradation,
while other types of Ub chains could regulate a variety of
cellular processes by both proteolytic and non-proteolytic
functions (Kulathu and Komander, 2012). Multiple key com-
ponents in canonical Wnt pathway are regulated by ubiqui-
tination, such as β-catenin, APC and Dvl (Chan et al., 2006;
Choi et al., 2004; Ding et al., 2013; Hu et al., 2010; Liu et al.,
1999; Liu et al., 2001; Tran et al., 2013; Tran and Polakis,
2012; Wei et al., 2012; Winston et al., 1999). Despite limited
reports so far on ubiquitination of Axin, it’s increasingly clear
that Axin is also subjected to ubiquitin modiﬁcation. Previ-
ously, Stegmeier lab revealed that Axin stability is regulated
by Tankyrase and Tankyrase-mediated poly-ADP-ribose
modiﬁcation (PARsylation) of Axin is linked to Axin polyub-
iquitylation and subsequent degradation by the proteasome
(Huang et al., 2009). Later, RNF146 was uncovered to be the
E3 ligase for mediating Tankyrase-dependent degradation of
Axin, thus playing a positive role in Wnt signaling (Callow
et al., 2011; Zhang et al., 2011). Ubiquitin-speciﬁc protease
34 (USP34) is also reported to associate with Axin and
control its levels, whereby modulating Wnt signaling (Lui
et al., 2011). Smurf2 (Smad ubiquitination regulatory factor
2), a C2-WW-HECT type ubiquitin ligase, is suggested to be
another E3 ligase for Axin, which also plays a role in regu-
lating its stability (Kim and Jho, 2010). Interestingly, we
recently uncovered that Smurf1, an isoform of Smurf2, also
targets Axin, but for a non-proteolytic purpose. Our data
suggested that Smurf1 ubiquitinates Axin through Lys
(K) 29-linked poly-ubiquitin chains, which disrupts its inter-
action with LRP5/6 rather than leads to its degradation (Fei
et al., 2013). Similar to Ubiquitination, SUMO modiﬁcation of
proteins also plays various roles in regulating protein func-
tion. However, researches regarding Axin SUMOylation are,
so far, very limited. It was reported earlier that SUMOylation
of Axin may regulate its function in noncanonical Wnt path-
way (Rui et al., 2002). Recently, Kim et al. suggested that
SUMOylation may protect Axin from ubiquitination, thus
playing a role in regulating Axin stability in canonical Wnt
pathway (Kim et al., 2008).
PHOSPHORYLATION/DEPHOSPHORYLATION
OF AXIN
Phosphorylation/Dephosphorylation is the most common
post-translational modiﬁcation for regulating protein function.
Multiple components of Wnt pathway, such as LRP5/6, Dvl,
β-catenin, TCF, are subject to reversible phosphorylation by
kinases and phosphatases networks. Axin, as a crucial
component of canonical Wnt pathway, is also under the
regulation of phosphorylation/dephosphorylation. Without
Wnt stimulation, Axin is phosphorylated, which enhances its
binding afﬁnity with β-catenin, leading to stabilization of Axin
(Jho et al., 1999; Yamamoto et al., 1999); upon Wnt stimu-
lation, Axin is dephosphorylated, leading to a less effective
binding with β-catenin and consequently Axin degradation
(Strovel et al., 2000; Willert et al., 1999). GSK3 is most likely
the key kinase that phosphorylates Axin and facilitates its
function in “destruction complex”. Besides GSK3, CKI was
also observed to phosphorylate Axin both in vitro and in vivo
(Gao et al., 2002). On the other hand, it is found that PP2A
and PP2C may be the two phosphatases targeting Axin
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(Strovel et al., 2000; Willert et al., 1999). Recently, it was
reported that phosphorylation of Axin by CKI may also
improve its association with GSK3 and leads to a more
active “destruction complex”, while protein phosphatase 1
(PP1) interacts with, and dephosphorylates Axin, reversing
the effect conferred by CKI and hence contributing to the
activation of Wnt signaling (Luo et al., 2007). Later, Jiang
et al. reported that Dab2 could block the interaction between
Axin and PP1, thus inhibiting Axin dephosphorylation and
ultimately leading to inhibition of the Wnt signaling (Jiang
et al., 2009). Previously, phosphorylation of Axin by Cyclin
A/CDK2 was reported to increase its association with
β-catenin (Kim et al., 2004). Recently, Axin was found to be
phosphorylated by CDK5, and this phosphorylation facili-
tates its interaction with GSK3, which plays an essential role
for axon development (Fang et al., 2011).
HOMO- AND HETERO-POLYMERIZATION OF AXIN
It is not unusual that proteins modulate their functions
through altering their oligomeric states or forming hetero-
oligomer with other proteins. Self- or hetero-assembly of
proteins also plays important roles in regulating Wnt signal-
ing. For example, aggregation of LRP5/6 is essential for Wnt
signaling activation, which may also require the oligomeri-
zation of Dvl (Metcalfe et al., 2010). Recently, we identiﬁed
Caprin-2 as a new component of canonical Wnt signaling
through facilitating LRP5/6 phosphorylation (Ding et al.,
2008), and we further found that the oligomerization of
Caprin-2 is required for its function in Wnt signaling
(unpublished data). Axin contains a DIX domain of 80 amino
acids located at its C-terminus for mediating homo- or het-
ero-interaction, which seems to be essential for its function
(Choi et al., 2010; Fiedler et al., 2011; Sakanaka and Wil-
liams, 1999; Yokoyama et al., 2012). The three-dimensional
structure of Axin DIX domain showed that it forms ﬁlaments
in the crystal through head-to-tail self-interaction (Schwarz-
Romond et al., 2007a; Shibata et al., 2007) (Fig. 1B).
Besides Axin, the homologous DIX domain is also present at
the N-terminus of Dvl and the C-terminus of Ccd1 (also
called DIXdc1) (Fig. 1A). It is argued that Dvl may release
Axin from the “destruction complex” and deliver Axin to the
“LRP signalosome” through DIX-mediated heterotypic inter-
actions between Dvl and Axin (Schwarz-Romond et al.,
2007b). Fiedler et al.’s recent work also indicated that Dvl
may behave as a dominant-negative modulator of Axin to
regulate its function via heterotypic interactions between
their DIX domains (Choi et al., 2010; Fiedler et al., 2011).
Ccd1 was initially identiﬁed as a positive regulator in Wnt
signaling (Shiomi et al., 2003). Ccd1-DIX interacts with Dvl-
DIX directly, converting latent polymeric Dvl to a biologically
active oligomer(s) (Liu et al., 2011; Shiomi et al., 2003).
However, the interaction between Ccd1 and Axin does not
seem to be dominated by their DIX domains and other
domains may also play an important role for their interaction
(Wong et al., 2004).
AUTO-INHIBITION OF AXIN
Conformational change is an important way for proteins to
regulate their functions. In many cases, when a protein







Figure 1. The C-terminal DIX domain of Axin mediates its homo/hetero- polyermerization. Schematic illustration of the domain
organization for Axin, Dvl and Ccd1. These three proteins all contain a DIX domain, which mediates their homo- and hetero-
interaction. The self-assembly of Axin-DIX or heterotypic interaction with Dvl-DIX may regulate Axin function in canonical Wnt
signaling. (B) The three-dimensional structure of Axin DIX domain (PDB code: 1wsp) showed that it forms ﬁlaments in the crystal
through head-to-tail self-interaction.
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substrates, or binding sites for other partners may be
blocked and thus this state is also referred to as an “inactive”
state; while, in an “active” state, the autoinhibitory confor-
mation is released, making the active or binding sites
available for interaction with substrates or regulatory part-
ners. Normally, this reversible process of conformational
change is induced and regulated by post-translational
modiﬁcations or interactions with other proteins. Previous
studies have suggested that Axin N-terminus (including the
RGS domain and the linker region between the RGS domain
and the GSK binding domain) plays an inhibitory role in
Axin’s binding with its partners (Chen et al., 2009; Mao et al.,
2001). However, the mechanism underlying such inhibition
remains elusive. In our recent work, we revealed that the
N-terminus of Axin is able to associate with its C-terminus,
forming a “closed” conformation, which could be disrupted
effectively by a small molecular compound, named as
HLY78. HLY78 is an activator of Wnt/β-catenin signaling
pathway identiﬁed by our group through high-throughput
screening, which acts in a Wnt ligand-dependent manner
(Wang et al., 2013). Our ﬁndings suggested that depending
on distinct partners and post-translational modiﬁcations, Axin
may undergo conformational change during its differential
assemblies with “destruction complex” or “Wnt-LRP5/6 sig-
nalosome”. We further found that HLY78 targets Axin-DIX
and triggers the conformational switch of Axin from a
“closed” auto-inhibitory state to an “open” active state,
leading to an enhanced association of Axin with LRP6 and
subsequent activation of LRP6. Meanwhile, an independent
work carried out by another group also proposed an “auto-
inhibition” model of Axin (Kim et al., 2013b). In their model,
phosphorylation by GSK3 makes Axin adopt an “open”
conformation for binding to β-catenin or phospho-LRP6,
while dephosphorylation by PP1 leads to a “closed” confor-
mation (auto-inhibition) of Axin, making Axin incompetent for
interacting with either β-catenin or phospho-LRP6. Notably,
according to their ﬁndings, the C-terminus of Axin forms a


















































Figure 2. The model of Axin autoinhibition. Based on the ﬁndings of Kim et al. and us, we proposed a possible model for Axin
“autoinhibiton”: without Wnt stimulation, the N-terminus of Axin interacts with its C-terminus, forming “type I” closed conformation,
which blocks its binding with LRP5/6 but spares the binding site for β-catenin; upon Wnt stimulation, this type I auto-inhibited state of
Axin is released for binding to LRP5/6 and the latter was subsequently phosphorylated, which inhibits the activity of GSK3 and thus
moves Axin towards to the dephosphorylated state conferred by PP1. Dephosphorylated Axin forms a “type II” closed conformation
through an intramolecular interaction between the C-terminus and the β-catenin binding region, making it unable to bind both of LRP5/
6 and β-catenin.
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with the middle β-catenin binding region rather than the
N-terminal region as we found. In our view, these two models
are not in conﬂict with each other and may function alter-
natively or collaboratively in different cellular contexts. A
possible model that accommodates both sets of ﬁndings is
proposed in Fig. 2: without Wnt stimulation, the N-terminus of
Axin interacts with its C-terminus, forming “type I” closed
conformation, which blocks its binding with LRP5/6 but
spares the one with β-catenin; upon Wnt stimulation, this
type I auto-inhibited state of Axin is released for binding to
LRP5/6 and the latter was subsequently phosphorylated,
which inhibits the activity of GSK3 and thus moves Axin
towards to the dephosphorylated state conferred by PP1.
Dephosphorylated Axin forms a “type II” closed conformation
through an intramolecular interaction between the C-termi-
nus and the β-catenin binding region, making it unable to
bind both of LRP5/6 and β-catenin.
MICRORNAS MEDIATED REGULATION OF AXIN
MicroRNA (miRNA) is a small noncoding RNA molecule
normally containing 19–25 nucleotides in length, which reg-
ulates gene expression both at transcriptional and post-
transcriptional level. So far, thousands of transcripts have
been reported to subject to microRNA regulation, playing
extensive and important roles in eukaryotic development and
physiology. Moreover, increasing evidences have implicated
the role of miRNA deregulation in human disease including
cancer. Recently, there are several researches addressing
potential roles of miRNAs in Axin regulation. In a screen for
miRNAs affecting Wnt pathway, Silver et al. found that
ectopic miR-315 directly inhibits Axin as well as Notum
(Silver et al., 2007), thus acting as an activator of Wnt sig-
naling. Later, another miRNA—hsa-miR-34a—reportedly
targets both the 5′-UTR and 3′-UTR of Axin2, whereby
repressing Axin2 expression (Lee et al., 2009). Recently,
Egea et al. revealed that lethal-7 (let-7) also targets and
represses the translation of Axin2. lethal-7 (let-7) is one of
the ﬁrst two known miRNAs (the other one is lin-4) (Reinhart
et al., 2000), which is highly conserved across species and
implicated in the regulation of a variety of important genes,
such as RAS and HMGA2 (Johnson et al., 2005; Mayr et al.,
2007). They found miRNA let-7f promotes β-catenin activity
in hMSCs by repressing the translation of Axin2 (Egea et al.,
2012). One the other hand, in a study lately published, Kim
et al. reported that upregulation of miR-205 in KB oral cancer
cells could trigger cell apoptosis. Further mechanistic study
identiﬁed Axin2 as the direct target of miR-205 (Lee et al.,
2013). They showed that over-expressed miR-205 in KB oral
cancer cells suppresses Axin2 expression through an inter-
action with its own binding site at Axin2 3′-UTR (64–92).
However, it is unclear how reduced Axin2 expression con-
ferred by miR-205, rather than facilitates tumorigenesis as it
usually does, contributes to the suppression of KB oral
cancer cells.
EPIGENETIC MODULATIONS OF AXIN IN CANCER
In additional to the post-transcriptional regulations mentioned
above in affecting Axin levels, epigenetic modulations could
also affect the expression of Axin and the change thereof
may relate to tumor development. It is well accepted that
genetic changes in components of Wnt signaling are closely
related with human cancer. One leading example is colorectal
cancer: alterations in Wnt-related genes, mainly APC, have
been observed in 90% of colorectal cancer (Miyaki et al.,
1994; Najdi et al., 2011). In addition to genetic mutations,
epigenetic modiﬁcation is another common cause for altered
gene expression, among which promoter methylation and
histone modiﬁcation are the most frequently observed. Axin is
also frequently found mutated in cancer, contributing to the
over-activation of Wnt signaling in these cancers, while
studies regarding epigenetic alterations of Axin and its rela-
tionship to cancer remain relatively scant. As a negative
regulator of Wnt signaling, tumor-speciﬁc promoter methyla-
tion or histone deacetylation will cause decreased Axin
expression, which may prompt over-activation of Wnt sig-
naling in cancer. Previously, epigenetic silencing of Axin2
was reported in colorectal carcinoma with microsatellite
instability (MSI+ CRC), and forced expression of Axin2
results in rapid cell death in an MSI+ CRC cell line, indicating
a role of epigenetic silencing of Axin2 in carcinogenesis of
MSI+ CRC (Koinuma et al., 2006). Lately, CpG islands of
Axin2 were found methylated in human neuroendocrine
tumors (NETs) and Axin2 expression is correspondingly
downregulated, which may contributes to the pathogenesis
and growth of NETs (Kim et al., 2013a). A recent work carried
out by Yang et al., also indicated that hypermethylated Axin
gene may signiﬁcantly correlate with the progression of lung
cancer (Yang et al., 2013). On the other hand, Chen G. et al.
reported that overexpression of Menin, a tumor suppressor
protein mutated in patients with multiple endocrine neoplasia
type 1, is associated with increased H3K4 trimethylation of
the Axin2 gene promoter; while, inhibition of Menin expres-
sion by siRNA abrogates H3K4 trimethylation and gene
expression of Axin2, indicating that Menin functions, at least
partly, through affecting histone trimethylation of Axin2 pro-
moter (Chen et al., 2008). Recently, Histone deacetylase
(HDAC) 1 and 2 are implicated in the regulation of Axin
expression in non-small cell lung cancer (NSCLC) (Han et al.,
2012). X-radiation and siRNA could inhibit expression of
HDAC1 and HDAC2 and weaken its inhibitory effect on Axin,
which upregulates Axin expression and induces apoptosis of
lung cancer cells (Han et al., 2012).
CONCLUDING REMARKS AND PERSPECTIVES
Besides those post-transcriptional modulations mentioned
above, another modiﬁcation—methylation—is also observed
for Axin (Cha et al., 2011; Huang et al., 2009). A recent work
carried out by Cha et al. revealed that PRMT1 directly
REVIEW Xiaomin Song et al.









interacts with and methylates Axin, thus enhancing Axin
stability (Cha et al., 2011; Huang et al., 2009). So far, our
knowledge about post-transcriptional modiﬁcations of Axin is
still very limited. More kinases, phosphatases, E3 ubiquitin
ligases and probably other types of post-transcriptional
regulations are expected to be identiﬁed in the near future to
ﬁt into the network that modulates Axin activity in canonical
Wnt signaling. In light of current ﬁndings, Axin seems to be a
ﬂexible and dynamic molecule, which could undergo struc-
tural rearrangements for interacting with distinct partners.
The three-dimensional structure of the full-length Axin will
provide invaluable insights into the details regarding Axin
auto-inhibition. On the other hand, increasing evidence
indicates a role of Axin in nucleus (Nikuseva Martic et al.,
2010; Pecina-Slaus et al., 2011; Schmitz et al., 2013; Willert
and Jones, 2006). However, the precise role of nuclear Axin
in Wnt signaling remains largely unknown, which warrants
further investigation to facilitate our understanding of the
function of nuclear Axin as well as its linkage to the cyto-
plasmic one. As an attractive therapeutic target, much effort
has been made to identify chemical compounds modulating
Axin activity. So far, most studies focus on small-molecules
in improving Axin stability and thus attenuating Wnt signal-
ing, among which inhibitors against Tankyrase are the best
explored (Bao et al., 2012; Huang et al., 2009; James et al.,
2012; Lu et al., 2009; Shultz et al., 2012). Tankyrase-medi-
ated PARsylation of Axin stimulates Axin degradation via the
ubiquitin-proteasome pathway (Huang et al., 2009). Thus, by
inhibiting Tankyrase activity, Axin is spared from the conse-
quent ubiquitination and degradation, which may antagonize
Wnt signaling and inhibit tumor growth. Wnt/β-catenin sig-
naling normally needs to be blocked for therapeutic purpose
in cancer; however, it also plays an important role in hema-
topoietic stem cell (HSC) formation and self-renewal, and is
required for HSC recovery after injury and in transplanta-
tion. Hence, our recent identiﬁcation of HLY78 as a novel
Wnt activator, may provide new chances for the circum-
stances where activation of Wnt signaling is desired, such as
for the patients with bone marrow failure or undergoing post-
HSC transplantation (Wang et al., 2013).
ACKNOWLEDGEMENTS
L.L and X.S would like to thank the National Basic Research Program
(973 Program) (Nos. 2010CB912100 to L.L, and 2011CD966300 to
X.S) and the National Natural Science Foundation of China (Grant
Nos. 31230044, 30930052 and 91213304 to L.L, and 31100532 to
X.S). X.S. gratefully acknowledges the support of SA-SIBS scholarship
program.
ABBREVIATIONS
APC, adenomatous polyposis coli; GSK3, glycogen synthase kinase
3; HDAC, histone deacetylase; HSC, hematopoietic stem cell; NETs,
neuroendocrine tumors; NSCLC, non-small cell lung cancer; Ub,
ubiquitin.
COMPLIANCE WITH ETHICS GUIDELINES
Xiaomin Song, Sheng Wang and Lin Li declare that they have no
conﬂict of interest.
This article does not contain any studies with human or animal
subjects performed by the any of the authors.
OPEN ACCESS
This article is distributed under the terms of the Creative Commons
Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and
the source are credited.
REFERENCES
Bao R, Christova T, Song S, Angers S, Yan X, Attisano L (2012)
Inhibition of tankyrases induces Axin stabilization and blocks Wnt
signalling in breast cancer cells. PLoS ONE 7:e48670
Bilic J, Huang YL, Davidson G, Zimmermann T, Cruciat CM, Bienz
M, Niehrs C (2007) Wnt induces LRP6 signalosomes and
promotes dishevelled-dependent LRP6 phosphorylation. Science
316:1619–1622
Callow MG, Tran H, Phu L, Lau T, Lee J, Sandoval WN, Liu PS,
Bheddah S, Tao J, Lill JR et al (2011) Ubiquitin ligase RNF146
regulates tankyrase and Axin to promote Wnt signaling. PLoS
ONE 6:e22595
Cha B, Kim W, Kim YK, Hwang BN, Park SY, Yoon JW, Park WS,
Cho JW, Bedford MT, Jho EH (2011) Methylation by protein
arginine methyltransferase 1 increases stability of Axin, a
negative regulator of Wnt signaling. Oncogene 30:2379–2389
Chan DW, Chan CY, Yam JW, Ching YP, Ng IO (2006) Prickle-1
negatively regulates Wnt/beta-catenin pathway by promoting
Dishevelled ubiquitination/degradation in liver cancer. Gastroen-
terology 131:1218–1227
Chen G, AJ, Wang M, Farley S, Lee LY, Lee LC, Sawicki MP (2008)
Menin promotes the Wnt signaling pathway in pancreatic endo-
crine cells. Mol Cancer Res 6:1894–1907
Chen T, Li M, Ding Y, Zhang LS, Xi Y, Pan WJ, Tao DL, Wang JY, Li L
(2009) Identiﬁcation of zinc-ﬁnger BED domain-containing 3
(Zbed3) as a novel Axin-interacting protein that activates Wnt/
beta-catenin signaling. J Biol Chem 284:6683–6689
Chia IV, Costantini F (2005) Mouse axin and axin2/conductin
proteins are functionally equivalent in vivo. Mol Cell Biol
25:4371–4376
Choi J, Park SY, Costantini F, Jho EH, Joo CK (2004) Adenomatous
polyposis coli is down-regulated by the ubiquitin-proteasome path-
way in a process facilitated by Axin. J Biol Chem 279:49188–49198
Choi SH, Choi KM, Ahn HJ (2010) Coexpression and protein-protein
complexing of DIX domains of human Dvl1 and Axin1 protein.
BMB Rep 43:609–613
Ding Y, Xi Y, Chen T, Wang JY, Tao DL, Wu ZL, Li YP, Li C, Zeng R, Li
L (2008) Caprin-2 enhances canonical Wnt signaling through
regulating LRP5/6 phosphorylation. J Cell Biol 182:865–872
Ding Y, Zhang Y, Xu C, Tao QH, Chen YG (2013) HECT domain-
containing E3 ubiquitin ligase NEDD4L negatively regulates Wnt
signaling by targeting dishevelled for proteasomal degradation.
J Biol Chem 288:8289–8298
Regulation of Axin function in canonical Wnt signaling pathway REVIEW









Egea V, Zahler S, Rieth N, Neth P, Popp T, Kehe K, JochumM, Ries C
(2012) Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates
mesenchymal stem cells through let-7f microRNA and Wnt/beta-
catenin signaling. Proc Natl Acad Sci USA 109:E309–E316
Fang WQ, Ip JP, Li R, Ng YP, Lin SC, Chen Y, Fu AK, Ip NY (2011)
Cdk5-mediated phosphorylation of Axin directs axon formation
during cerebral cortex development. J Neurosci 31:13613–13624
Fei C, Li Z, Li C, Chen Y, Chen Z, He X, Mao L, Wang X, Zeng R, Li L
(2013) Smurf1-mediated Lys29-linked non-proteolytic poly-ubiq-
uitination of Axin negatively regulates Wnt/beta-catenin signaling.
Mol Cell Biol 33:4095–4105
Fiedler M, Mendoza-Topaz C, Rutherford TJ, Mieszczanek J, Bienz
M (2011) Dishevelled interacts with the DIX domain polymeriza-
tion interface of Axin to interfere with its function in down-
regulating beta-catenin. Proc Natl Acad Sci USA 108:1937–1942
Gao ZH, Seeling JM, Hill V, Yochum A, Virshup DM (2002) Casein
kinase I phosphorylates and destabilizes the beta-catenin deg-
radation complex. Proc Natl Acad Sci USA 99:1182–1187
Han Y, Zhang Y, Yang LH, Mi XY, Dai SD, Li QC, Xu HT, Yu JH, Li G,
Zhao J et al (2012) X-radiation inhibits histone deacetylase 1 and
2, upregulates Axin expression and induces apoptosis in non-
small cell lung cancer. Radiat Oncol 7:183
Hu T, Li C, Cao Z, Van Raay TJ, Smith JG, Willert K, Solnica-Krezel
L, Coffey RJ (2010) Myristoylated Naked2 antagonizes Wnt-beta-
catenin activity by degrading Dishevelled-1 at the plasma
membrane. J Biol Chem 285:13561–13568
Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud
GA, Charlat O, Wiellette E, Zhang Y, Wiessner S et al (2009)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signal-
ling. Nature 461:614–620
James RG, Davidson KC, Bosch KA, Biechele TL, Robin NC, Taylor
RJ, Major MB, Camp ND, Fowler K, Martins TJ et al (2012)
WIKI4, a novel inhibitor of tankyrase and Wnt/ss-catenin signal-
ing. PLoS ONE 7:e50457
Jho E, Lomvardas S, Costantini F (1999) A GSK3beta phosphor-
ylation site in axin modulates interaction with beta-catenin and
Tcf-mediated gene expression. Biochem Biophys Res Commun
266:28–35
Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F (2002)
Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2,
a negative regulator of the signaling pathway. Mol Cell Biol
22:1172–1183
Jiang Y, LuoW, Howe PH (2009) Dab2 stabilizes Axin and attenuates
Wnt/beta-catenin signaling by preventing protein phosphatase 1
(PP1)–Axin interactions. Oncogene 28:2999–3007
Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng
A, Labourier E, Reinert KL, Brown D, Slack FJ (2005) RAS is
regulated by the let-7 microRNA family. Cell 120:635–647
Kim S, Jho EH (2010) The protein stability of Axin, a negative
regulator of Wnt signaling, is regulated by Smad ubiquitination
regulatory factor 2 (Smurf2). J Biol Chem 285:36420–36426
Kim SI, Park CS, Lee MS, Kwon MS, Jho EH, Song WK (2004)
Cyclin-dependent kinase 2 regulates the interaction of Axin with
beta-catenin. Biochem Biophys Res Commun 317:478–483
Kim MJ, Chia IV, Costantini F (2008) SUMOylation target sites at the
C terminus protect Axin from ubiquitination and confer protein
stability. FASEB J 22:3785–3794
Kim JT, Li J, Jang ER, Gulhati P, Rychahou PG, Napier DL, Wang C,
Weiss HL, Lee EY, Anthony L et al (2013a) Deregulation of Wnt/
beta-catenin signaling through genetic or epigenetic alterations in
human neuroendocrine tumors. Carcinogenesis 34:953–961
Kim SE, Huang H, Zhao M, Zhang X, Zhang A, Semonov MV,
MacDonald BT, Zhang X, Garcia Abreu J, Peng L et al (2013b)
Wnt stabilization of beta-catenin reveals principles for morphogen
receptor-scaffold assemblies. Science 340:867–870
Koinuma K, Yamashita Y, Liu W, Hatanaka H, Kurashina K, Wada T,
Takada S, Kaneda R, Choi YL, Fujiwara SI et al (2006)
Epigenetic silencing of AXIN2 in colorectal carcinoma with
microsatellite instability. Oncogene 25:139–146
Kulathu Y, Komander D (2012) Atypical ubiquitylation - the unex-
plored world of polyubiquitin beyond Lys48 and Lys63 linkages.
Nat Rev Mol Cell Biol 13:508–523
Lee I, Ajay SS, Yook JI, Kim HS, Hong SH, Kim NH, Dhanasekaran
SM, Chinnaiyan AM, Athey BD (2009) New class of microRNA
targets containing simultaneous 5′-UTR and 3′-UTR interaction
sites. Genome Res 19:1175–1183
Lee MA, Kim WK, Park HJ, Kang SS, Lee SK (2013) Anti-
proliferative activity of hydnocarpin, a natural lignan, is asso-
ciated with the suppression of Wnt/beta-catenin signaling
pathway in colon cancer cells. Bioorg Med Chem Lett
23:5511–5514
Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, Cho KR,
Fearon ER (2002) Activation of AXIN2 expression by beta-
catenin-T cell factor. A feedback repressor pathway regulating
Wnt signaling. J Biol Chem 277:21657–21665
Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP,
Mohammed S, Heck AJ, Maurice MM, Mahmoudi T et al (2012)
Wnt signaling through inhibition of beta-catenin degradation in an
intact Axin1 complex. Cell 149:1245–1256
Liu C, Kato Y, Zhang Z, Do VM, Yankner BA, He X (1999) beta-
Trcp couples beta-catenin phosphorylation-degradation and
regulates Xenopus axis formation. Proc Natl Acad Sci USA
96:6273–6278
Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, White RL,
Matsunami N (2001) Siah-1 mediates a novel beta-catenin
degradation pathway linking p53 to the adenomatous polyposis
coli protein. Mol Cell 7:927–936
Liu YT, Dan QJ, Wang J, Feng Y, Chen L, Liang J, Li Q, Lin SC,
Wang ZX, Wu JW (2011) Molecular basis of Wnt activation via the
DIX domain protein Ccd1. J Biol Chem 286:8597–8608
Lu J, Ma Z, Hsieh JC, Fan CW, Chen B, Longgood JC, Williams NS,
Amatruda JF, Lum L, Chen C (2009) Structure-activity relation-
ship studies of small-molecule inhibitors of Wnt response. Bioorg
Med Chem Lett 19:3825–3827
Lui TT, Lacroix C, Ahmed SM, Goldenberg SJ, Leach CA, Daulat
AM, Angers S (2011) The ubiquitin-speciﬁc protease USP34
regulates axin stability and Wnt/beta-catenin signaling. Mol Cell
Biol 31:2053–2065
Luo W, Peterson A, Garcia BA, Coombs G, Kofahl B, Heinrich R,
Shabanowitz J, Hunt DF, Yost HJ, Virshup DM (2007) Protein
phosphatase 1 regulates assembly and function of the beta-
catenin degradation complex. EMBO J 26:1511–1521
Mao J, Wang J, Liu B, Pan W, Farr GH 3rd, Flynn C, Yuan H, Takada
S, Kimelman D, Li L et al (2001) Low-density lipoprotein receptor-
REVIEW Xiaomin Song et al.









related protein-5 binds to Axin and regulates the canonical Wnt
signaling pathway. Mol Cell 7:801–809
Mayr C, Hemann MT, Bartel DP (2007) Disrupting the pairing
between let-7 and Hmga2 enhances oncogenic transformation.
Science 315:1576–1579
Mendoza-Topaz C, Mieszczanek J, Bienz M (2011) The Adenoma-
tous polyposis coli tumour suppressor is essential for Axin
complex assembly and function and opposes Axin’s interaction
with Dishevelled. Open Biol 1:110013
MetcalfeC,Mendoza-TopazC,MieszczanekJ,BienzM(2010)Stability
elements in theLRP6cytoplasmic tail confer efﬁcientsignallingupon
DIX-dependent polymerization. J Cell Sci 123:1588–1599
MiyakiM, KonishiM, Kikuchi-YanoshitaR, EnomotoM, Igari T, Tanaka
K, Muraoka M, Takahashi H, Amada Y, Fukayama M et al (1994)
Characteristics of somatic mutation of the adenomatous polyposis
coli gene in colorectal tumors. Cancer Res 54:3011–3020
Najdi R, Holcombe RF, Waterman ML (2011) Wnt signaling and
colon carcinogenesis: beyond APC. J Carcinog 10:5
Nikuseva Martic T, Pecina-Slaus N, Kusec V, Kokotovic T, Musinovic
H, Tomas D, Zeljko M (2010) Changes of AXIN-1 and beta-catenin
in neuroepithelial brain tumors. Pathol Oncol Res 16:75–79
Pecina-Slaus N, Martic TN, Kokotovic T, Kusec V, Tomas D,
Hrascan R (2011) AXIN-1 protein expression and localization in
glioblastoma. Collegium Antropologicum 35(Suppl 1):101–106
Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC,
Rougvie AE, Horvitz HR, Ruvkun G (2000) The 21-nucleotide let-
7 RNA regulates developmental timing in Caenorhabditis ele-
gans. Nature 403:901–906
Rui HL, Fan E, Zhou HM, Xu Z, Zhang Y, Lin SC (2002) SUMO-1
modiﬁcation of the C-terminal KVEKVD of Axin is required for
JNK activation but has no effect on Wnt signaling. J Biol Chem
277:42981–42986
Sakanaka C, Williams LT (1999) Functional domains of axin.
Importance of the C terminus as an oligomerization domain.
J Biol Chem 274:14090–14093
Schmitz Y, Rateitschak K, Wolkenhauer O (2013) Analysing the
impact of nucleo-cytoplasmic shuttling of beta-catenin and its
antagonists APC, Axin and GSK3 on Wnt/beta-catenin signalling.
Cell Signal 25:2210–2221
Schwarz-Romond T, Fiedler M, Shibata N, Butler PJ, Kikuchi A, Higuchi
Y, Bienz M (2007a) The DIX domain of Dishevelled confers Wnt
signaling by dynamicpolymerization.NatStructMolBiol 14:484–492
Schwarz-Romond T, Metcalfe C, Bienz M (2007b) Dynamic recruit-
ment of axin by Dishevelled protein assemblies. J Cell Sci
120:2402–2412
Shibata N, Tomimoto Y, Hanamura T, Yamamoto R, Ueda M, Ueda
Y, Mizuno N, Ogata H, Komori H, Shomura Y et al (2007)
Crystallization and preliminary X-ray crystallographic studies of
the axin DIX domain. Acta Crystallogr Sect F Struct Biol Cryst
Commun 63:529–531
Shiomi K, Uchida H, Keino-Masu K, Masu M (2003) Ccd1, a
novel protein with a DIX domain, is a positive regulator in the Wnt
signaling during zebraﬁsh neural patterning. Curr Biol 13:73–77
Shultz MD, Kirby CA, Stams T, Chin DN, Blank J, Charlat O, Cheng
H, Cheung A, Cong F, Feng Y et al (2012) [1,2,4]triazol-3-
ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: antagonists of the
Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine
pocket binding. J Med Chem 55:1127–1136
Silver SJ, Hagen JW, Okamura K, Perrimon N, Lai EC (2007)
Functional screening identiﬁes miR-315 as a potent activator of
Wingless signaling. Proc Natl Acad Sci USA 104:18151–18156
Strovel ET, Wu D, Sussman DJ (2000) Protein phosphatase
2Calpha dephosphorylates axin and activates LEF-1-dependent
transcription. J Biol Chem 275:2399–2403
Tran H, Polakis P (2012) Reversible modiﬁcation of adenomatous
polyposis coli (APC) with K63-linked polyubiquitin regulates the
assembly and activity of the beta-catenin destruction complex.
J Biol Chem 287:28552–28563
Tran H, Bustos D, Yeh R, Rubinfeld B, Lam C, Shriver S, Zilberleyb I,
Lee MW, Phu L, Sarkar AA et al (2013) HectD1 E3 ligase
modiﬁes adenomatous polyposis coli (APC) with polyubiquitin to
promote the APC-axin interaction. J Biol Chem 288:3753–3767
Wang S, Yin J, Chen D, Nie F, Song X, Fei C, Miao H, Jing C, Ma W,
Wang L et al (2013) Small-moleculemodulation ofWnt signaling via
modulating the Axin-LRP5/6 interaction. Nat Chem Biol 9:579–585
Wei W, Li M, Wang J, Nie F, Li L (2012) The E3 ubiquitin ligase ITCH
negatively regulates canonical Wnt signaling by targeting dishev-
elled protein. Mol Cell Biol 32:3903–3912
Willert K, Jones KA (2006) Wnt signaling: is the party in the nucleus?
Genes Dev 20:1394–1404
Willert K, Shibamoto S, Nusse R (1999) Wnt-induced dephospho-
rylation of axin releases beta-catenin from the axin complex.
Genes Dev 13:1768–1773
Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper
JW (1999) The SCFbeta-TRCP-ubiquitin ligase complex associ-
ates speciﬁcally with phosphorylated destruction motifs in Ikap-
paBalpha and beta-catenin and stimulates IkappaBalpha
ubiquitination in vitro. Genes Dev 13:270–283
Wong CK, Luo W, Deng Y, Zou H, Ye Z, Lin SC (2004) The DIX
domain protein coiled-coil-DIX1 inhibits c-Jun N-terminal kinase
activation by Axin and dishevelled through distinct mechanisms.
J Biol Chem 279:39366–39373
Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, Kikuchi A
(1999) Phosphorylation of axin, a Wnt signal negative regulator,
by glycogen synthase kinase-3beta regulates its stability. J Biol
Chem 274:10681–10684
Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L,
Sakamoto D, Caothien RH, Fuller JH, Reinhard C et al (2001)
Elevated expression of axin2 and hnkd mRNA provides evidence
that Wnt/beta -catenin signaling is activated in human colon
tumors. Proc Natl Acad Sci USA 98:14973–14978
Yang LH, Xu HT, Li QC, Jiang GY, Zhang XP, Zhao HY, Xu K, Wang
EH (2013) Abnormal hypermethylation and clinicopathological
signiﬁcance of Axin gene in lung cancer. Tumour Biol 34:749–757
Yokoyama N, Markova NG, Wang HY, Malbon CC (2012) Assembly
of Dishevelled 3-based supermolecular complexes via phosphor-
ylation and Axin. J Mol Signal 7:8
Zhang Y, Liu S, Mickanin C, Feng Y, Charlat O, Michaud GA, Schirle
M, Shi X, Hild M, Bauer A et al (2011) RNF146 is a poly(ADP-
ribose)-directed E3 ligase that regulates axin degradation and
Wnt signalling. Nat Cell Biol 13:623–629
Regulation of Axin function in canonical Wnt signaling pathway REVIEW
© The Author(s) 2014. This article is published with open access at Springerlink.com and journal.hep.com.cn 193
P
ro
te
in
&
C
e
ll
